Cayman Court Strips ATP III GP of Control Over Biotech Fund

The court appointed Alexander Lawson and Barry Lynch of Alvarez & Marsal to assume control of the fund with immediate effect. This decision displaces the firm’s current leadership, headed by Dr. Seth Harrison, ending his tenure as General Partner. The Rigmora Biotech Investors, who pushed for the change, stated that the transition to independent management is essential to protect the fund’s assets and maximize its long-term value. The move represents a significant shift in the governance of the venture capital entity, placing professional office holders in charge of the fund’s future operations.